FLEXION THERAPEUTICS INC - COM (FLXN)

CUSIP: 33938J106

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / COM
Total 13F shares
36,101,124
Share change
-2,180,937
Total reported value
$408,708,860
Put/Call ratio
46%
Price per share
$11.32
Number of holders
121
Value change
-$40,591,382
Number of buys
49
Number of sells
66

Quarterly Holders Quick Answers

What is CUSIP 33938J106?
CUSIP 33938J106 identifies FLXN - FLEXION THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FLEXION THERAPEUTICS INC - COM (FLXN) as of Q4 2018

As of 31 Dec 2018, FLEXION THERAPEUTICS INC - COM (FLXN) was held by 121 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 36,101,124 shares. The largest 10 holders included MILLER VALUE PARTNERS, LLC, BlackRock Inc., GILDER GAGNON HOWE & CO LLC, Capital World Investors, STATE STREET CORP, WELLS FARGO & COMPANY/MN, Vanguard Group Inc, Bank of New York Mellon Corp, PICTET ASSET MANAGEMENT LTD, and MORGAN STANLEY. This page lists 121 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.